Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001179110-18-010987)

Filing Details

Accession Number:: 0001179110-18-010987
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-08-29 14:51:10
Reporting Period:: 2018-08-28

Accepted Time:: 2018-08-29 14:51:10
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1235007	Endocyte Inc	ECYT	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1522046	Beth Taylor	3000 Kent Ave, Ste A1-100 West Lafayette IN 47906	Vp Finance & Chief Acctg Offcr	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2018-08-28	7,892	$20.00	63,363	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

Represents the sale of 7,892 shares in a single transaction, at a price per share of $20.0000. The shares were sold by Merrill Lynch pursuant to a written plan as specified in Rule 10b5-1(c) of the Securities Exchange Act of 1934.